ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastric Cancer Drugs Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-34H7060
Home | Market Reports | Health| Health Conditions| Cancer
Global Gastric Cancer Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Gastric Cancer Drugs Market Research Report 2025

Code: QYRE-Auto-34H7060
Report
August 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Eli Lilly
F.Hoffmann-La Roche
Otsuka Pharmaceutical
Novartis
Amgen Inc
Merck
Astrazeneca plc
Boehringer Ingelheim
Daiichi Sankyo
Bayer HealthCare

Gastric Cancer Drugs Market Size

The global market for Gastric Cancer Drugs was valued at US$ 1442 million in the year 2024 and is projected to reach a revised size of US$ 2598 million by 2031, growing at a CAGR of 8.9% during the forecast period.

Gastric Cancer Drugs Market

Gastric Cancer Drugs Market

Gastric cancer drugs are used to treat malignancies, or cancerous growths.
The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive market share of nearly 45% during the forecast period.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gastric Cancer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Cancer Drugs.
The Gastric Cancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastric Cancer Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastric Cancer Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Gastric Cancer Drugs Market Report

Report Metric Details
Report Name Gastric Cancer Drugs Market
Accounted market size in year US$ 1442 million
Forecasted market size in 2031 US$ 2598 million
CAGR 8.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Doxorubicin Hydrochloride
  • Sunitinib
  • Docetaxel
  • Mitomycin
  • Fluorouracil
  • Imatinib
  • Trastuzumab
Segment by Application
  • Hospitals
  • Clinics
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Eli Lilly, F. Hoffmann-La Roche, Otsuka Pharmaceutical, Novartis, Amgen, Merck, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Bayer HealthCare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Gastric Cancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Gastric Cancer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Gastric Cancer Drugs Market growing?

Ans: The Gastric Cancer Drugs Market witnessing a CAGR of 8.9% during the forecast period 2025-2031.

What is the Gastric Cancer Drugs Market size in 2031?

Ans: The Gastric Cancer Drugs Market size in 2031 will be US$ 2598 million.

Who are the main players in the Gastric Cancer Drugs Market report?

Ans: The main players in the Gastric Cancer Drugs Market are Sanofi, Eli Lilly, F. Hoffmann-La Roche, Otsuka Pharmaceutical, Novartis, Amgen, Merck, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Bayer HealthCare

What are the Application segmentation covered in the Gastric Cancer Drugs Market report?

Ans: The Applications covered in the Gastric Cancer Drugs Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Gastric Cancer Drugs Market report?

Ans: The Types covered in the Gastric Cancer Drugs Market report are Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab

1 Gastric Cancer Drugs Market Overview
1.1 Product Definition
1.2 Gastric Cancer Drugs by Type
1.2.1 Global Gastric Cancer Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Doxorubicin Hydrochloride
1.2.3 Sunitinib
1.2.4 Docetaxel
1.2.5 Mitomycin
1.2.6 Fluorouracil
1.2.7 Imatinib
1.2.8 Trastuzumab
1.3 Gastric Cancer Drugs by Application
1.3.1 Global Gastric Cancer Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Gastric Cancer Drugs Market Size Estimates and Forecasts
1.4.1 Global Gastric Cancer Drugs Revenue 2020-2031
1.4.2 Global Gastric Cancer Drugs Sales 2020-2031
1.4.3 Global Gastric Cancer Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Gastric Cancer Drugs Market Competition by Manufacturers
2.1 Global Gastric Cancer Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Gastric Cancer Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Gastric Cancer Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Gastric Cancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gastric Cancer Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gastric Cancer Drugs, Product Type & Application
2.7 Global Key Manufacturers of Gastric Cancer Drugs, Date of Enter into This Industry
2.8 Global Gastric Cancer Drugs Market Competitive Situation and Trends
2.8.1 Global Gastric Cancer Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Gastric Cancer Drugs Players Market Share by Revenue
2.8.3 Global Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Gastric Cancer Drugs Market Scenario by Region
3.1 Global Gastric Cancer Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Gastric Cancer Drugs Sales by Region: 2020-2031
3.2.1 Global Gastric Cancer Drugs Sales by Region: 2020-2025
3.2.2 Global Gastric Cancer Drugs Sales by Region: 2026-2031
3.3 Global Gastric Cancer Drugs Revenue by Region: 2020-2031
3.3.1 Global Gastric Cancer Drugs Revenue by Region: 2020-2025
3.3.2 Global Gastric Cancer Drugs Revenue by Region: 2026-2031
3.4 North America Gastric Cancer Drugs Market Facts & Figures by Country
3.4.1 North America Gastric Cancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Gastric Cancer Drugs Sales by Country (2020-2031)
3.4.3 North America Gastric Cancer Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gastric Cancer Drugs Market Facts & Figures by Country
3.5.1 Europe Gastric Cancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Gastric Cancer Drugs Sales by Country (2020-2031)
3.5.3 Europe Gastric Cancer Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gastric Cancer Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Gastric Cancer Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Gastric Cancer Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Gastric Cancer Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gastric Cancer Drugs Market Facts & Figures by Country
3.7.1 Latin America Gastric Cancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Gastric Cancer Drugs Sales by Country (2020-2031)
3.7.3 Latin America Gastric Cancer Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gastric Cancer Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Gastric Cancer Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Gastric Cancer Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Gastric Cancer Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gastric Cancer Drugs Sales by Type (2020-2031)
4.1.1 Global Gastric Cancer Drugs Sales by Type (2020-2025)
4.1.2 Global Gastric Cancer Drugs Sales by Type (2026-2031)
4.1.3 Global Gastric Cancer Drugs Sales Market Share by Type (2020-2031)
4.2 Global Gastric Cancer Drugs Revenue by Type (2020-2031)
4.2.1 Global Gastric Cancer Drugs Revenue by Type (2020-2025)
4.2.2 Global Gastric Cancer Drugs Revenue by Type (2026-2031)
4.2.3 Global Gastric Cancer Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Gastric Cancer Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Gastric Cancer Drugs Sales by Application (2020-2031)
5.1.1 Global Gastric Cancer Drugs Sales by Application (2020-2025)
5.1.2 Global Gastric Cancer Drugs Sales by Application (2026-2031)
5.1.3 Global Gastric Cancer Drugs Sales Market Share by Application (2020-2031)
5.2 Global Gastric Cancer Drugs Revenue by Application (2020-2031)
5.2.1 Global Gastric Cancer Drugs Revenue by Application (2020-2025)
5.2.2 Global Gastric Cancer Drugs Revenue by Application (2026-2031)
5.2.3 Global Gastric Cancer Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Gastric Cancer Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Gastric Cancer Drugs Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly Gastric Cancer Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 F. Hoffmann-La Roche
6.3.1 F. Hoffmann-La Roche Company Information
6.3.2 F. Hoffmann-La Roche Description and Business Overview
6.3.3 F. Hoffmann-La Roche Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 F. Hoffmann-La Roche Gastric Cancer Drugs Product Portfolio
6.3.5 F. Hoffmann-La Roche Recent Developments/Updates
6.4 Otsuka Pharmaceutical
6.4.1 Otsuka Pharmaceutical Company Information
6.4.2 Otsuka Pharmaceutical Description and Business Overview
6.4.3 Otsuka Pharmaceutical Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Otsuka Pharmaceutical Gastric Cancer Drugs Product Portfolio
6.4.5 Otsuka Pharmaceutical Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Gastric Cancer Drugs Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Company Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amgen Gastric Cancer Drugs Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Gastric Cancer Drugs Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AstraZeneca Gastric Cancer Drugs Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Company Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Ingelheim Gastric Cancer Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 Daiichi-Sankyo
6.10.1 Daiichi-Sankyo Company Information
6.10.2 Daiichi-Sankyo Description and Business Overview
6.10.3 Daiichi-Sankyo Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Daiichi-Sankyo Gastric Cancer Drugs Product Portfolio
6.10.5 Daiichi-Sankyo Recent Developments/Updates
6.11 Bayer HealthCare
6.11.1 Bayer HealthCare Company Information
6.11.2 Bayer HealthCare Description and Business Overview
6.11.3 Bayer HealthCare Gastric Cancer Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bayer HealthCare Gastric Cancer Drugs Product Portfolio
6.11.5 Bayer HealthCare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gastric Cancer Drugs Industry Chain Analysis
7.2 Gastric Cancer Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gastric Cancer Drugs Production Mode & Process Analysis
7.4 Gastric Cancer Drugs Sales and Marketing
7.4.1 Gastric Cancer Drugs Sales Channels
7.4.2 Gastric Cancer Drugs Distributors
7.5 Gastric Cancer Drugs Customer Analysis
8 Gastric Cancer Drugs Market Dynamics
8.1 Gastric Cancer Drugs Industry Trends
8.2 Gastric Cancer Drugs Market Drivers
8.3 Gastric Cancer Drugs Market Challenges
8.4 Gastric Cancer Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Eli Lilly
F.Hoffmann-La Roche
Otsuka Pharmaceutical
Novartis
Amgen Inc
Merck
Astrazeneca plc
Boehringer Ingelheim
Daiichi Sankyo
Bayer HealthCare
List of Tables
 Table 1. Global Gastric Cancer Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Gastric Cancer Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Gastric Cancer Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Gastric Cancer Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Gastric Cancer Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Gastric Cancer Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Gastric Cancer Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Gastric Cancer Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Gastric Cancer Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Gastric Cancer Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Gastric Cancer Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Gastric Cancer Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Gastric Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Cancer Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Gastric Cancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Gastric Cancer Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Gastric Cancer Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Gastric Cancer Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Gastric Cancer Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Gastric Cancer Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Gastric Cancer Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Gastric Cancer Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Gastric Cancer Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Gastric Cancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Gastric Cancer Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Gastric Cancer Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Gastric Cancer Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Gastric Cancer Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Gastric Cancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Gastric Cancer Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Gastric Cancer Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Gastric Cancer Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Gastric Cancer Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Gastric Cancer Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Gastric Cancer Drugs Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Gastric Cancer Drugs Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Gastric Cancer Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Gastric Cancer Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gastric Cancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Gastric Cancer Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Gastric Cancer Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Gastric Cancer Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Gastric Cancer Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Gastric Cancer Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Gastric Cancer Drugs Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Gastric Cancer Drugs Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Gastric Cancer Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Gastric Cancer Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Gastric Cancer Drugs Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Gastric Cancer Drugs Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Gastric Cancer Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Gastric Cancer Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Gastric Cancer Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Gastric Cancer Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Gastric Cancer Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Gastric Cancer Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Gastric Cancer Drugs Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Gastric Cancer Drugs Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Gastric Cancer Drugs Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Gastric Cancer Drugs Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Gastric Cancer Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Gastric Cancer Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Gastric Cancer Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Gastric Cancer Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Gastric Cancer Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Gastric Cancer Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Gastric Cancer Drugs Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Gastric Cancer Drugs Price (USD/Pcs) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Sanofi Gastric Cancer Drugs Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Eli Lilly Gastric Cancer Drugs Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. F. Hoffmann-La Roche Company Information
 Table 81. F. Hoffmann-La Roche Description and Business Overview
 Table 82. F. Hoffmann-La Roche Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. F. Hoffmann-La Roche Gastric Cancer Drugs Product
 Table 84. F. Hoffmann-La Roche Recent Developments/Updates
 Table 85. Otsuka Pharmaceutical Company Information
 Table 86. Otsuka Pharmaceutical Description and Business Overview
 Table 87. Otsuka Pharmaceutical Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Otsuka Pharmaceutical Gastric Cancer Drugs Product
 Table 89. Otsuka Pharmaceutical Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Novartis Gastric Cancer Drugs Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Amgen Company Information
 Table 96. Amgen Description and Business Overview
 Table 97. Amgen Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Amgen Gastric Cancer Drugs Product
 Table 99. Amgen Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Merck Gastric Cancer Drugs Product
 Table 104. Merck Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. AstraZeneca Gastric Cancer Drugs Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Boehringer Ingelheim Company Information
 Table 111. Boehringer Ingelheim Description and Business Overview
 Table 112. Boehringer Ingelheim Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Boehringer Ingelheim Gastric Cancer Drugs Product
 Table 114. Boehringer Ingelheim Recent Developments/Updates
 Table 115. Daiichi-Sankyo Company Information
 Table 116. Daiichi-Sankyo Description and Business Overview
 Table 117. Daiichi-Sankyo Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 118. Daiichi-Sankyo Gastric Cancer Drugs Product
 Table 119. Daiichi-Sankyo Recent Developments/Updates
 Table 120. Bayer HealthCare Company Information
 Table 121. Bayer HealthCare Description and Business Overview
 Table 122. Bayer HealthCare Gastric Cancer Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 123. Bayer HealthCare Gastric Cancer Drugs Product
 Table 124. Bayer HealthCare Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Gastric Cancer Drugs Distributors List
 Table 128. Gastric Cancer Drugs Customers List
 Table 129. Gastric Cancer Drugs Market Trends
 Table 130. Gastric Cancer Drugs Market Drivers
 Table 131. Gastric Cancer Drugs Market Challenges
 Table 132. Gastric Cancer Drugs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Gastric Cancer Drugs
 Figure 2. Global Gastric Cancer Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gastric Cancer Drugs Market Share by Type: 2024 & 2031
 Figure 4. Doxorubicin Hydrochloride Product Picture
 Figure 5. Sunitinib Product Picture
 Figure 6. Docetaxel Product Picture
 Figure 7. Mitomycin Product Picture
 Figure 8. Fluorouracil Product Picture
 Figure 9. Imatinib Product Picture
 Figure 10. Trastuzumab Product Picture
 Figure 11. Global Gastric Cancer Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Gastric Cancer Drugs Market Share by Application: 2024 & 2031
 Figure 13. Hospitals
 Figure 14. Clinics
 Figure 15. Other
 Figure 16. Global Gastric Cancer Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Gastric Cancer Drugs Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Gastric Cancer Drugs Sales (2020-2031) & (K Pcs)
 Figure 19. Global Gastric Cancer Drugs Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Gastric Cancer Drugs Report Years Considered
 Figure 21. Gastric Cancer Drugs Sales Share by Manufacturers in 2024
 Figure 22. Global Gastric Cancer Drugs Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Gastric Cancer Drugs Players: Market Share by Revenue in Gastric Cancer Drugs in 2024
 Figure 24. Gastric Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Gastric Cancer Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Gastric Cancer Drugs Sales Market Share by Country (2020-2031)
 Figure 27. North America Gastric Cancer Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Gastric Cancer Drugs Sales Market Share by Country (2020-2031)
 Figure 31. Europe Gastric Cancer Drugs Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Gastric Cancer Drugs Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Gastric Cancer Drugs Revenue Market Share by Region (2020-2031)
 Figure 39. China Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Gastric Cancer Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Gastric Cancer Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Gastric Cancer Drugs Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Gastric Cancer Drugs Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. UAE Gastric Cancer Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Gastric Cancer Drugs by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Gastric Cancer Drugs by Type (2020-2031)
 Figure 61. Global Gastric Cancer Drugs Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Gastric Cancer Drugs by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Gastric Cancer Drugs by Application (2020-2031)
 Figure 64. Global Gastric Cancer Drugs Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Gastric Cancer Drugs Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Stomach Cancer Drugs Market Insights Forecast to 2030
Gastric Carcinomas Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stomach Cancer and Gastric Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Treatment Drugs Market
Stomach Cancer and Gastric Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gastrointestinal Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptic Ulcer Disease Medication Market Research Report 2025
Global Stomach Medicine Market Research Report 2024
Global Anticancer Drugs Market Research Report 2025
Global OTC Gastrointestinal Products Market Research Report 2024
Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oncology Small Molecule Drugs Market Insights Forecast to 2030
Global Gastric Treatment Equipment Market Research Report 2024
Global Antiulcerant Drugs Market Insights Forecast to 2030
Global Metastatic Cancer Treat Drug Market Research Report 2025
Global Anti Peptic Ulcer Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Breast Cancer Drugs Market Insights Forecast to 2030
Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptic Ulcer Medication Market Research Report 2024
Global Busulfan Drugs Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions